McKesson Corp. (MCK) announced Monday that it has entered into an agreement to sell its Austrian business to Quadrifolia Management GmbH. The sale includes McKesson Austria's Herba Chemosan Apotheker-AG, together with Sanova Pharma GesmbH. Financial terms of the deal were not disclosed.
The transaction is part of McKesson's broader enterprise strategy to exit Europe and continue to evaluate suitable exit alternatives for its businesses in Norway and Denmark. It recently agreed o sell McKesson Europe businesses in UK, France, Italy, Ireland, Portugal, Belgium, and Slovenia.
Meanwhile, Quadrifolia will be conducting a management buyout which will see the existing management of the Austrian business buy all of the Herba Chemosan Apotheker-AG and Sanova Pharma GesmbH, backed by Invest AG.
The transaction is expected to close in fiscal 2022, subject to customary closing conditions, including receipt of required regulatory approvals.
For comments and feedback contact: editorial@rttnews.com
Business News
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.